Canadian Cancer Trials Group Bulletins

Trial Management Group

NCI US PMB Change of Address and Phone Numbers

Effective March 25, 2013 the NCI US Pharmaceutical Management Branch (PMB) will be moving. This affects the following trials as drug is currently distributed by the NCI US PMB - CL.3, CM.1, MDC.1, CRC.6, HEC.1, NEC.2, and BRC.2.

Complete information is posted on each of the affected trial's website. Please review the memo and note the timelines for the move and the new addresses and phone numbers.

Any questions about this should be directed to Christine Bertrim at (613) 533-6430 or